Sloan accruals ratio beyond ±25%
The Sloan accruals ratio is (net income - operating cash flow - investing cash flow) / total assets. A wide gap between book profit and actual cash flow signals low earnings quality; in practice, within ±10% is normal and beyond ±25% is a warning. Note that a growth company investing heavily can trip this screen on investing outflows alone — check whether a big investment year is behind it. This lens is not a buy signal — it is a screen for stocks to avoid.
A screen for what to avoid — not a buy signal.
This lens has no Track Record summary yet — only scored signals are shown on the Track Record page. The table below is the current pass list.
| Stock | Accruals ratio | Net income | Operating cash flow | Investing cash flow | Price since latest filing |
|---|---|---|---|---|---|
| ALIGOS THERAPEUTICS INC (ALGS) | 108.6% | $-24.2M | $-82.5M | $-37.8M | -75.0% · 13F Jul 1 |
| CURIS INC (CRIS) | 85.7% | $-7.6M | $-27.2M | $2.5M | -93.5% · 13F Jul 1 |
| Infleqtion, Inc. (INFQ) | 82.0% | $-66.9M | $-2.3M | $-413.0M | -41.7% · 13F Jul 1 |
| Veradermics, Inc (MANE) | 78.9% | $-70.0M | $-71.6M | $-118.9M | +27.6% · 13D Aug 24 |
| CYTOMX THERAPEUTICS INC (CTMX) | 77.8% | $-17.4M | $-75.6M | $-59.7M | -46.1% · 13F Jul 1 |
| BICARA THERAPEUTICS INC (BCAX) | 66.7% | $-137.9M | $-106.8M | $-318.5M | -66.8% · 13F Jul 1 |
| NOVAVAX INC (NVAX) | 64.9% | $440.3M | $-244.6M | $-78.3M | -15.9% · 13F Jul 1 |
| MAPLIGHT THERAPEUTICS INC (MPLT) | 62.6% | $-161.2M | $-138.1M | $-323.2M | -45.9% · 13D Aug 19 |
| JADE BIOSCIENCES INC (JBIO) | 61.3% | $-127.4M | $-94.7M | $-247.0M | -29.4% · 13F Jul 1 |
| ASSEMBLY BIOSCIENCES INC (ASMB) | 57.6% | $-6.1M | $-41.1M | $-113.5M | -15.7% · 13F Jul 1 |
| MINERALYS THERAPEUTICS INC (MLYS) | 57.0% | $-154.7M | $-142.4M | $-389.8M | -46.2% · 13F Jul 1 |
| EVOMMUNE INC (EVMN) | 54.6% | $-68.9M | $-76.4M | $-115.3M | -45.2% · 13F Jul 1 |
| COLUMBUS MCKINNON CORP (CMCO) | 49.6% | $-229.5M | $-146.2M | $-2.5B | -2.3% · Form 4 Nov 10 |
| AVALO THERAPEUTICS INC (AVTX) | 47.2% | $-78.3M | $-51.5M | $-81.7M | -58.8% · 13F Jul 1 |
| MACROGENICS INC (MGNX) | 46.9% | $-74.6M | $-81.0M | $-114.1M | -55.6% · 13F Jul 1 |
| DISC MEDICINE INC (IRON) | 44.9% | $-212.2M | $-180.4M | $-394.3M | +2.2% · 13F Jul 1 |
| MONOPAR THERAPEUTICS INC (MNPR) | 44.0% | $-13.7M | $-12.2M | $-63.5M | -25.2% · 13F Jul 1 |
| Beta Bionics, Inc. (BBNX) | 42.8% | $-73.2M | $-50.9M | $-162.8M | -11.9% · 13F Jul 1 |
| Altimmune, Inc. (ALT) | 40.0% | $-88.1M | $-67.5M | $-132.5M | -51.4% · 13F Jul 1 |
| MAZE THERAPEUTICS INC (MAZE) | 38.2% | $-131.1M | $-111.9M | $-171.0M | +10.3% · 13F Jul 1 |
| LSI INDUSTRIES INC (LYTS) | 38.0% | $22.6M | $44.1M | $-336.6M | -26.2% · Form 4 Aug 25 |
| ACADIA PHARMACEUTICALS INC (ACAD) | 37.3% | $391.0M | $109.8M | $-302.6M | -27.3% · 13F Jul 1 |
| MANNKIND CORP (MNKD) | 36.9% | $5.9M | $18.3M | $-304.8M | +0.5% · 13F Jul 1 |
| ALKAMI TECHNOLOGY, INC. (ALKT) | 36.2% | $-47.7M | $42.9M | $-397.6M | -28.1% · 13F Jul 1 |
| NOVA LTD. (NVMI) | 36.0% | $259.2M | $245.6M | $-837.2M | -38.6% · 13F Jul 1 |
| COGENT BIOSCIENCES INC (COGT) | 35.7% | $-328.9M | $-264.4M | $-399.5M | -27.6% · 13F Jul 1 |
| CORVUS PHARMACEUTICALS INC (CRVS) | 35.6% | $-15.3M | $-32.8M | $-7.8M | -4.1% · Form 4 Nov 16 |
| CLEANSPARK INC (CLSK) | 35.5% | $364.5M | $-461.0M | $-305.7M | -54.9% · 13F Jul 1 |
| BELITE BIO, INC (BLTE) | 33.9% | $-77.6M | $-37.0M | $-305.1M | +10.8% · 13F Jul 1 |
| NVIDIA CORP (NVDA) | 33.6% | $120.1B | $102.7B | $-52.2B | -21.3% · 13F Jul 1 |
| LEXEO THERAPEUTICS INC (LXEO) | 33.1% | $-100.0M | $-98.6M | $-90.3M | -35.8% · 13F Jul 1 |
| BIOAGE LABS INC (BIOA) | 32.6% | $-80.6M | $-81.6M | $-95.2M | -79.0% · 13F Jul 1 |
| Nebius Group N.V. (NBIS) | 31.6% | $82.5M | $384.8M | $-4.2B | -25.0% · Form 4 Nov 2 |
| Oklo Inc. (OKLO) | 30.5% | $-105.7M | $-82.2M | $-489.7M | -53.3% · 13D Jul 7 |
| Strategy Inc (MSTR) | 30.4% | $-3.8B | $-67.2M | $-22.5B | +3.3% · 13F Jul 1 |
| COHEN & STEERS, INC. (CNS) | 30.3% | $153.2M | $-120.4M | $8.4M | -11.7% · 13F Jul 1 |
| JOYY Inc. (JOYY) | 29.8% | $2.1B | $302.3M | $-456.1M | +17.8% · 13F Jul 1 |
| APPLIED OPTOELECTRONICS, INC. (AAOI) | 29.7% | $-38.2M | $-174.4M | $-210.6M | -67.5% · 13F Jul 1 |
| ENLIVEN THERAPEUTICS INC (ELVN) | 29.5% | $-103.7M | $-70.3M | $-173.8M | -3.9% · 13F Jul 1 |
| NOVAGOLD RESOURCES INC (NG) | 28.9% | $-94.7M | $-14.0M | $-177.6M | -7.4% · 13D Jul 24 |
| LITHIUM AMERICAS CORP (LAC) | 28.7% | $-86.3M | $-61.2M | $-765.0M | -63.2% · 13F Jul 1 |
| Shift4 Payments, Inc. (FOUR) | 28.5% | $119.0M | $634.0M | $-3.0B | -15.8% · 13F Jul 1 |
| HERC HOLDINGS INC (HRI) | 28.0% | $1.0M | $1.1B | $-4.9B | +0.7% · Form 4 Aug 25 |
| CG ONCOLOGY INC (CGON) | 27.4% | $-161.0M | $-132.3M | $-245.8M | +11.4% · 13F Jul 1 |
| James Hardie Industries plc (JHX) | 27.2% | $104.0M | $589.8M | $-4.2B | +3.5% · 13F Jul 1 |
| CARETRUST REIT INC (CTRE) | 27.0% | $320.5M | $394.0M | $-1.5B | -9.2% · 13F Jul 1 |
| JANUX THERAPEUTICS INC (JANX) | 26.9% | $-113.6M | $-82.2M | $-301.0M | -26.9% · 13F Jul 1 |
| Applied Digital Corp. (APLD) | 26.8% | $-184.3M | $89.7M | $-2.9B | -26.4% · Form 4 Oct 20 |
| Millrose Properties, Inc. (MRP) | 26.2% | $379.9M | $3.7B | $-5.7B | -15.5% · 13F Jul 1 |
| Beam Therapeutics Inc. (BEAM) | 26.1% | $-80.0M | $-345.1M | $-121.4M | -38.3% · 13F Jul 1 |
| KYMERA THERAPEUTICS INC (KYMR) | 25.4% | $-311.4M | $-232.9M | $-521.1M | +6.4% · 13F Jul 1 |
| AST SpaceMobile, Inc. (ASTS) | 25.3% | $-341.9M | $-71.5M | $-1.5B | -55.8% · Form 4 Sep 2 |
| Indivior Pharmaceuticals, Inc. (INDV) | 25.2% | $210.0M | $-27.0M | $-66.0M | +4.0% · Form 4 Aug 28 |
| BROWN & BROWN, INC. (BRO) | 25.1% | $1.1B | $1.4B | $-7.9B | +7.3% · 13F Jul 1 |
| Kodiak Sciences Inc. (KOD) | -26.6% | $-230.0M | $-136.0M | $-506.0K | -9.6% · Form 4 Nov 9 |
| BridgeBio Pharma, Inc. (BBIO) | -28.1% | $-732.9M | $-445.9M | $-24.5M | -7.4% · 13D Aug 18 |
| Intellia Therapeutics, Inc. (NTLA) | -29.2% | $-412.7M | $-394.7M | $228.0M | -43.3% · 13F Jul 1 |
| agilon health, inc. (AGL) | -29.4% | $-391.3M | $-105.8M | $88.6M | +3.1% · 13F Jul 1 |
| Arlo Technologies, Inc. (ARLO) | -29.5% | $14.9M | $78.7M | $27.8M | -0.3% · Form 4 Nov 11 |
| MongoDB, Inc. (MDB) | -29.7% | $-71.2M | $505.1M | $538.8M | -16.9% · 13F Jul 1 |
| Leslie's, Inc. (LESL) | -29.7% | $-237.0M | $8.8M | $-25.4M | -99.7% · 13F Jul 1 |
| JELD-WEN Holding, Inc. (JELD) | -30.1% | $-621.2M | $-4.9M | $16.3M | -51.7% · 13F Jul 1 |
| Evolent Health, Inc. (EVH) | -30.2% | $-534.5M | $38.8M | $-233.0K | -19.5% · 13F Jul 1 |
| EchoStar CORP (ECHO) | -30.2% | $-14.5B | $-99.4M | $-1.4B | -4.8% · Form 4 Nov 10 |
| FLYEXCLUSIVE INC. (FLYX) | -30.3% | $-17.6M | $6.7M | $108.9M | -52.9% · 13F Jul 1 |
| Enovis CORP (ENOV) | -31.9% | $-1.2B | $217.3M | $-179.4M | +0.0% · Form 4 Nov 17 |
| ERASCA INC (ERAS) | -32.7% | $-124.5M | $-95.5M | $100.4M | -22.5% · 13F Jul 1 |
| ALLOGENE THERAPEUTICS INC (ALLO) | -33.0% | $-190.9M | $-149.2M | $95.6M | -51.7% · 13D Oct 1 |
| Liberty Global Ltd. (LBTYA) | -33.1% | $-7.1B | $1.2B | $-874.9M | -9.1% · 13F Jul 1 |
| Liberty Global Ltd. (LBTYK) | -33.1% | $-7.1B | $1.2B | $-874.9M | -8.1% · 13F Jul 1 |
| AURA BIOSCIENCES INC (AURA) | -33.7% | $-106.2M | $-84.7M | $35.6M | +6.2% · 13F Jul 1 |
| Cardlytics, Inc. (CDLX) | -34.1% | $-103.5M | $9.3M | $-15.3M | -71.0% · 13F Jul 1 |
| Andersen Group Inc. (ANDG) | -35.0% | $-2.3M | $184.6M | $10.6M | +71.0% · 13F Jul 1 |
| Brightstar Lottery PLC (BRSL) | -35.5% | $147.0M | $-99.0M | $3.5B | -19.7% · 13F Jul 1 |
| EASTMAN KODAK CO (KODK) | -35.8% | $-128.0M | $480.0M | $-29.0M | +0.0% · Form 4 Nov 17 |
| Capri Holdings Ltd (CPRI) | -35.8% | $137.0M | $77.0M | $1.2B | +2.9% · 13F Jul 1 |
| CAPRICOR THERAPEUTICS INC (CAPR) | -37.3% | $-105.0M | $-69.8M | $97.5M | -63.5% · 13F Jul 1 |
| ALUMIS INC (ALMS) | -39.2% | $-243.3M | $-369.5M | $287.9M | -51.1% · Form 4 Sep 10 |
| Chime Financial, Inc. (CHYM) | -39.4% | $-1.0B | $52.8M | $-289.7M | +56.9% · 13F Jul 1 |
| AMTECH SYSTEMS INC (ASYS) | -40.2% | $-30.3M | $7.9M | $-912.0K | -18.0% · Form 4 Sep 17 |
| ACLARIS THERAPEUTICS INC (ACRS) | -41.2% | $-64.9M | $-47.1M | $48.4M | -36.7% · 13F Jul 1 |
| FRACTYL HEALTH, INC. (GUTS) | -41.2% | $-141.0M | $-90.3M | $-557.0K | -86.4% · Form 4 Sep 17 |
| Celldex Therapeutics, Inc. (CLDX) | -44.1% | $-258.8M | $-210.9M | $209.1M | -23.8% · 13F Jul 1 |
| HARLEY-DAVIDSON, INC. (HOG) | -49.8% | $338.7M | $568.9M | $3.8B | +37.8% · 13F Jul 1 |
| Cullinan Therapeutics, Inc. (CGEM) | -50.0% | $-219.9M | $-175.8M | $180.0M | -46.3% · 13F Jul 1 |
| Ecovyst Inc. (ECVT) | -51.3% | $-71.1M | $140.3M | $435.4M | -2.0% · Form 4 Sep 15 |
| Gain Therapeutics, Inc. (GANX) | -53.7% | $-20.4M | $-18.9M | $5.0M | -40.7% · 13F Jul 1 |
| Artiva Biotherapeutics, Inc. (ARTV) | -53.9% | $-83.9M | $-76.8M | $63.4M | -61.5% · 13D Jul 24 |
| ARRAY DIGITAL INFRASTRUCTURE, INC. (AD) | -55.4% | $48.8M | $200.8M | $2.4B | -29.7% · 13D Sep 3 |
| ANTERIS TECHNOLOGIES GLOBAL (AVR) | -68.5% | $-94.1M | $-77.8M | $-596.0K | -21.4% · Form 4 Oct 9 |
| Damora Therapeutics, Inc. (DMRA) | -71.3% | $-209.8M | $-6.7M | $-17.4M | +9.2% · Form 4 Sep 29 |
| EDITAS MEDICINE INC (EDIT) | -71.6% | $-160.1M | $-165.2M | $138.7M | -44.4% · 13F Jul 1 |
| Annexon, Inc. (ANNX) | -75.8% | $-206.7M | $-186.4M | $190.1M | -13.5% · Form 4 Sep 28 |
| Hinge Health, Inc. (HNGE) | -78.7% | $-528.3M | $171.4M | $-113.8M | +34.5% · 13F Jul 1 |
| Caribou Biosciences, Inc. (CRBU) | -79.5% | $-148.1M | $-111.0M | $102.2M | -80.6% · 13F Jul 1 |
| FAETH THERAPEUTICS INC (FTH) | -89.1% | $-21.1M | $-20.5M | $19.8M | -61.8% · 13F Jul 1 |
| Lumentum Holdings Inc. (LITE) | -94.4% | $-6.9B | $751.4M | $-785.5M | -30.1% · 13F Jul 1 |
| LARIMAR THERAPEUTICS INC (LRMR) | -104.8% | $-165.7M | $-113.2M | $100.3M | -6.9% · 13F Jul 1 |
| ACUMEN PHARMACEUTICALS INC (ABOS) | -113.8% | $-121.3M | $-115.5M | $133.9M | -91.1% · 13F Jul 1 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | -169.6% | $-101.7M | $-84.1M | $82.6M | -51.2% · 13F Jul 1 |
| Stock | Accruals ratio | Net income | Operating cash flow | Investing cash flow | Price since latest filing |
|---|---|---|---|---|---|
| SAB BIOTHERAPEUTICS INC (SABS) | 104.0% | $13.3M | $-44.8M | $-121.7M | -21.5% · 13D Aug 11 |
| Q32 BIO INC (QTTB) | 91.2% | $29.8M | $-33.5M | $7.0M | -44.0% · 13D Jul 21 |
| PROTARA THERAPEUTIC INC (TARA) | 66.1% | $-57.4M | $-56.4M | $-139.5M | -42.6% · 13F Jul 1 |
| QXO, Inc. (QXO) | 63.5% | $-279.4M | $261.4M | $-10.6B | -32.8% · 13F Jul 1 |
| Hyperliquid Strategies Inc (PURR) | 53.5% | $305.5M | $-19.1M | $-777.4M | -3.0% · 13F Jul 1 |
| Pony AI Inc. (PONY) | 50.8% | $-134.0M | $-165.0M | $-889.2M | -45.3% · 13F Jul 1 |
| Trevi Therapeutics, Inc. (TRVI) | 48.3% | $-42.8M | $-42.1M | $-94.1M | -23.3% · 13F Jul 1 |
| OVID THERAPEUTICS INC (OVID) | 46.9% | $-17.4M | $-38.3M | $-49.9M | -17.2% · 13F Jul 1 |
| WHITEHAWK THERAPEUTICS INC (WHWK) | 43.1% | $-20.6M | $-97.4M | $11.9M | -28.4% · 13F Jul 1 |
| WESTERN DIGITAL CORP (WDC) | 42.7% | $9.4B | $3.9B | $-429.0M | -52.6% · 13F Jul 1 |
| uniQure N.V. (QURE) | 36.4% | $-199.0M | $-178.0M | $-321.6M | -54.0% · 13F Jul 1 |
| Sionna Therapeutics, Inc. (SION) | 33.7% | $-75.3M | $-66.3M | $-118.7M | -49.0% · 13D Sep 22 |
| Construction Partners, Inc. (ROAD) | 33.7% | $101.8M | $291.3M | $-1.3B | -7.7% · Form 4 Nov 9 |
| SYNOPSYS INC (SNPS) | 32.6% | $1.3B | $1.5B | $-15.9B | -4.2% · 13F Jul 1 |
| Vital Farms, Inc. (VITL) | 32.2% | $66.3M | $33.7M | $-134.3M | -31.4% · 13F Jul 1 |
| STOKE THERAPEUTICS INC (STOK) | 32.1% | $-6.9M | $45.6M | $-186.8M | -19.3% · 13F Jul 1 |
| RAPPORT THERAPEUTICS INC (RAPP) | 31.9% | $-111.5M | $-87.5M | $-187.5M | -5.5% · Form 4 Nov 2 |
| Oric Pharmaceuticals, Inc. (ORIC) | 31.7% | $-129.5M | $-111.0M | $-148.0M | -26.5% · 13F Jul 1 |
| WhiteFiber, Inc. (WYFI) | 30.2% | $-24.7M | $45.7M | $-267.3M | -57.5% · 13D Aug 26 |
| PTC THERAPEUTICS, INC. (PTCT) | 28.7% | $682.6M | $711.2M | $-862.0M | -26.0% · 13F Jul 1 |
| Talen Energy Corp (TLN) | 28.2% | $-219.0M | $704.0M | $-4.0B | -1.7% · 13F Jul 1 |
| Praxis Precision Medicines, Inc. (PRAX) | 27.4% | $-303.3M | $-249.1M | $-311.1M | -4.5% · 13F Jul 1 |
| Olema Pharmaceuticals, Inc. (OLMA) | 26.2% | $-162.5M | $-146.7M | $-155.8M | -40.2% · 13F Jul 1 |
| Palantir Technologies Inc. (PLTR) | 25.6% | $1.6B | $2.1B | $-2.8B | +24.5% · 13F Jul 1 |
| Verastem, Inc. (VSTM) | -25.3% | $-209.5M | $-137.5M | $-9.6M | +80.7% · 13F Jul 1 |
| UroGen Pharma Ltd. (URGN) | -26.2% | $-153.5M | $-162.4M | $61.6M | -21.3% · 13F Jul 1 |
| Wise Group plc (WSE) | -26.4% | $498.7M | $7.6B | $1.7B | -7.8% · 13F Jul 1 |
| VERISIGN INC/CA (VRSN) | -28.2% | $825.7M | $1.1B | $109.1M | +6.0% · Form 4 Sep 1 |
| Zai Lab Ltd (ZLAB) | -28.4% | $-175.5M | $-150.8M | $307.9M | +0.3% · Form 4 Nov 16 |
| SYNAPTICS Inc (SYNA) | -31.1% | $-490.8M | $149.4M | $13.0M | -7.4% · 13F Jul 1 |
| Snowflake Inc. (SNOW) | -31.4% | $-1.3B | $1.2B | $312.2M | +4.5% · 13F Jul 1 |
| RingCentral, Inc. (RNG) | -31.5% | $43.4M | $617.4M | $-108.0M | +75.7% · 13F Jul 1 |
| SKYX Platforms Corp. (SKYX) | -31.5% | $-33.4M | $-13.3M | $-1.9M | -53.7% · 13D Jul 14 |
| TELEPHONE & DATA SYSTEMS INC /DE/ (TDS) | -32.6% | $-6.2M | $589.9M | $2.1B | -18.4% · 13D Sep 3 |
| SUTRO BIOPHARMA INC (STRO) | -33.9% | $-191.1M | $-177.2M | $45.0M | -70.5% · 13F Jul 1 |
| VERA THERAPEUTICS INC (VERA) | -34.4% | $-299.6M | $-241.1M | $194.3M | -38.6% · 13F Jul 1 |
| TYRA BIOSCIENCES INC (TYRA) | -34.4% | $-119.9M | $-95.1M | $72.5M | -23.9% · 13D Sep 18 |
| SUN COMMUNITIES INC (SUI) | -34.9% | $1.4B | $864.2M | $4.9B | -3.2% · 13F Jul 1 |
| PLUG POWER INC (PLUG) | -36.9% | $-1.6B | $-535.8M | $-139.0M | -60.2% · 13F Jul 1 |
| ThredUp Inc. (TDUP) | -36.9% | $-71.2M | $-22.6M | $43.7M | +0.0% · Form 4 Nov 10 |
| Relay Therapeutics, Inc. (RLAY) | -37.6% | $-276.5M | $-235.5M | $192.8M | -7.3% · 13F Jul 1 |
| QUANTUM CORP /DE/ (QMCO) | -39.2% | $-101.0M | $-37.9M | $-1.7M | +31.3% · 13F Jul 1 |
| SOLAREDGE TECHNOLOGIES, INC. (SEDG) | -40.8% | $-405.4M | $104.3M | $379.9M | -61.2% · 13F Jul 1 |
| StubHub Holdings, Inc. (STUB) | -40.8% | $-1.9B | $192.6M | $-34.4M | -64.8% · 13F Jul 1 |
| Ralliant Corp (RAL) | -41.4% | $-1.2B | $397.6M | $-37.7M | -6.1% · 13F Jul 1 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | -41.4% | $-223.1M | $-190.0M | $103.8M | -40.1% · 13F Jul 1 |
| Rallybio Corp (RLYB) | -42.5% | $-9.0M | $-29.8M | $47.3M | -4.1% · 13F Jul 1 |
| XENON PHARMACEUTICALS INC (XENE) | -45.0% | $-345.9M | $-279.1M | $218.0M | +2.0% · Form 4 Oct 2 |
| Resolute Holdings Management, Inc. (RHLD) | -45.2% | $-5.9M | $196.1M | $-51.4M | +0.4% · Form 4 Aug 25 |
| Velo3D, Inc. (VELO) | -45.2% | $-71.4M | $-27.3M | $-2.7M | -79.7% · 13F Jul 1 |
| Syndax Pharmaceuticals Inc (SNDX) | -47.7% | $-285.4M | $-323.0M | $290.0M | -56.0% · 13F Jul 1 |
| Rafael Holdings, Inc. (RFL) | -48.8% | $-30.5M | $-18.9M | $44.0M | -75.8% · 13F Jul 1 |
| Simulations Plus, Inc. (SLP) | -65.5% | $-64.7M | $18.1M | $3.6M | +0.8% · 13F Jul 1 |
| PRELUDE THERAPEUTICS INC (PRLD) | -68.4% | $-99.5M | $-56.3M | $53.5M | -32.4% · 13F Jul 1 |
| Scholar Rock Holding Corp (SRRK) | -73.4% | $-377.9M | $-300.0M | $218.7M | +4.2% · Form 4 Oct 28 |
| SUMMIT THERAPEUTICS INC (SMMT) | -77.5% | $-1.1B | $-322.9M | $-174.3M | -25.8% · 13F Jul 1 |
| REPLIMUNE GROUP INC (REPL) | -103.6% | $-313.9M | $-280.3M | $310.8M | +29.2% · 13D Aug 12 |
| PRECIGEN, INC. (PGEN) | -103.7% | $-250.6M | $-87.8M | $-1.5M | -42.2% · Form 4 Aug 26 |
| VOR BIOPHARMA INC (VOR) | -108.7% | $-696.0M | $-142.7M | $-48.8M | -6.8% · 13D Jul 22 |
More in Red Flags: Earnings Manipulation Suspect (Beneish) · Distress Risk (Altman Z″) · Financial Restatement (8-K 4.02) · Auditor Change (8-K 4.01) · Late Filings (NT).
For education only — not investment advice. Past records do not guarantee future results. How each number is measured: Methodology.
Earnings Manipulation Suspect (Beneish) · Track Record: how 13F signals scored · Practice timing
One email a week: the week’s new filings and research. Subscribe free
← Distress Risk (Altman Z″) · Financial Restatement (8-K 4.02) →
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.